Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice

Hiroaki Masuzaki, Hiroshi Yamamoto, Christopher J. Kenyon, Joel K. Elmquist, Nicholas M. Morton, Janice M. Paterson, Hiroshi Shinyama, Matthew G F Sharp, Stewart Fleming, John J. Mullins, Jonathan R. Seckl, Jeffrey S. Flier

Research output: Contribution to journalArticle

Abstract

Obesity is closely associated with the metabolic syndrome, a combination of disorders including insulin resistance, diabetes, dyslipidemia, and hypertension. A role for local glucocorticoid reamplification in obesity and the metabolic syndrome has been suggested. The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) regenerates active cortisol from inactive 11-keto forms, and aP2-HSD1 mice with relative transgenic overexpression of this enzyme in fat cells develop visceral obesity with insulin resistance and dyslipidemia. Here we report that aP2-HSD1 mice also have high arterial blood pressure (BP). The mice have increased sensitivity to dietary salt and increased plasma levels of angiotensinogen, angiotensin II, and aldosterone. This hypertension is abolished by selective angiotensin II receptor AT-1 antagonist at a low dose that does not affect BP in non-Tg littermates. These findings suggest that activation of the circulating renin-angiotensin system (RAS) develops in aP2-HSD1 mice. The long-term hypertension is further reflected by an appreciable hypertrophy and hyperplasia of the distal tubule epithelium of the nephron, resembling salt-sensitive or angiotensin II-mediated hypertension. Taken together, our findings suggest that overexpression of 1 11β-HSD1 in fat is sufficient to cause salt-sensitive hypertension mediated by an activated RAS. The potential role of adipose 11β-HSD1 in mediating critical features of the metabolic syndrome extends beyond obesity and metabolic complications to include the most central cardiovascular feature of this disorder.

Original languageEnglish (US)
Pages (from-to)83-90
Number of pages8
JournalJournal of Clinical Investigation
Volume112
Issue number1
DOIs
StatePublished - Jul 2003

Fingerprint

Glucocorticoids
Adipose Tissue
11-beta-Hydroxysteroid Dehydrogenases
Hypertension
Obesity
Salts
Renin-Angiotensin System
Dyslipidemias
Angiotensin II
Insulin Resistance
Angiotensinogen
Angiotensin Receptors
Abdominal Obesity
Nephrons
Enzymes
Aldosterone
Adipocytes
Hypertrophy
Hyperplasia
Hydrocortisone

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. / Masuzaki, Hiroaki; Yamamoto, Hiroshi; Kenyon, Christopher J.; Elmquist, Joel K.; Morton, Nicholas M.; Paterson, Janice M.; Shinyama, Hiroshi; Sharp, Matthew G F; Fleming, Stewart; Mullins, John J.; Seckl, Jonathan R.; Flier, Jeffrey S.

In: Journal of Clinical Investigation, Vol. 112, No. 1, 07.2003, p. 83-90.

Research output: Contribution to journalArticle

Masuzaki, H, Yamamoto, H, Kenyon, CJ, Elmquist, JK, Morton, NM, Paterson, JM, Shinyama, H, Sharp, MGF, Fleming, S, Mullins, JJ, Seckl, JR & Flier, JS 2003, 'Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice', Journal of Clinical Investigation, vol. 112, no. 1, pp. 83-90. https://doi.org/10.1172/JCI200317845
Masuzaki, Hiroaki ; Yamamoto, Hiroshi ; Kenyon, Christopher J. ; Elmquist, Joel K. ; Morton, Nicholas M. ; Paterson, Janice M. ; Shinyama, Hiroshi ; Sharp, Matthew G F ; Fleming, Stewart ; Mullins, John J. ; Seckl, Jonathan R. ; Flier, Jeffrey S. / Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. In: Journal of Clinical Investigation. 2003 ; Vol. 112, No. 1. pp. 83-90.
@article{5936ba2671554f64a6fc73fdd8de1a40,
title = "Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice",
abstract = "Obesity is closely associated with the metabolic syndrome, a combination of disorders including insulin resistance, diabetes, dyslipidemia, and hypertension. A role for local glucocorticoid reamplification in obesity and the metabolic syndrome has been suggested. The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) regenerates active cortisol from inactive 11-keto forms, and aP2-HSD1 mice with relative transgenic overexpression of this enzyme in fat cells develop visceral obesity with insulin resistance and dyslipidemia. Here we report that aP2-HSD1 mice also have high arterial blood pressure (BP). The mice have increased sensitivity to dietary salt and increased plasma levels of angiotensinogen, angiotensin II, and aldosterone. This hypertension is abolished by selective angiotensin II receptor AT-1 antagonist at a low dose that does not affect BP in non-Tg littermates. These findings suggest that activation of the circulating renin-angiotensin system (RAS) develops in aP2-HSD1 mice. The long-term hypertension is further reflected by an appreciable hypertrophy and hyperplasia of the distal tubule epithelium of the nephron, resembling salt-sensitive or angiotensin II-mediated hypertension. Taken together, our findings suggest that overexpression of 1 11β-HSD1 in fat is sufficient to cause salt-sensitive hypertension mediated by an activated RAS. The potential role of adipose 11β-HSD1 in mediating critical features of the metabolic syndrome extends beyond obesity and metabolic complications to include the most central cardiovascular feature of this disorder.",
author = "Hiroaki Masuzaki and Hiroshi Yamamoto and Kenyon, {Christopher J.} and Elmquist, {Joel K.} and Morton, {Nicholas M.} and Paterson, {Janice M.} and Hiroshi Shinyama and Sharp, {Matthew G F} and Stewart Fleming and Mullins, {John J.} and Seckl, {Jonathan R.} and Flier, {Jeffrey S.}",
year = "2003",
month = "7",
doi = "10.1172/JCI200317845",
language = "English (US)",
volume = "112",
pages = "83--90",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice

AU - Masuzaki, Hiroaki

AU - Yamamoto, Hiroshi

AU - Kenyon, Christopher J.

AU - Elmquist, Joel K.

AU - Morton, Nicholas M.

AU - Paterson, Janice M.

AU - Shinyama, Hiroshi

AU - Sharp, Matthew G F

AU - Fleming, Stewart

AU - Mullins, John J.

AU - Seckl, Jonathan R.

AU - Flier, Jeffrey S.

PY - 2003/7

Y1 - 2003/7

N2 - Obesity is closely associated with the metabolic syndrome, a combination of disorders including insulin resistance, diabetes, dyslipidemia, and hypertension. A role for local glucocorticoid reamplification in obesity and the metabolic syndrome has been suggested. The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) regenerates active cortisol from inactive 11-keto forms, and aP2-HSD1 mice with relative transgenic overexpression of this enzyme in fat cells develop visceral obesity with insulin resistance and dyslipidemia. Here we report that aP2-HSD1 mice also have high arterial blood pressure (BP). The mice have increased sensitivity to dietary salt and increased plasma levels of angiotensinogen, angiotensin II, and aldosterone. This hypertension is abolished by selective angiotensin II receptor AT-1 antagonist at a low dose that does not affect BP in non-Tg littermates. These findings suggest that activation of the circulating renin-angiotensin system (RAS) develops in aP2-HSD1 mice. The long-term hypertension is further reflected by an appreciable hypertrophy and hyperplasia of the distal tubule epithelium of the nephron, resembling salt-sensitive or angiotensin II-mediated hypertension. Taken together, our findings suggest that overexpression of 1 11β-HSD1 in fat is sufficient to cause salt-sensitive hypertension mediated by an activated RAS. The potential role of adipose 11β-HSD1 in mediating critical features of the metabolic syndrome extends beyond obesity and metabolic complications to include the most central cardiovascular feature of this disorder.

AB - Obesity is closely associated with the metabolic syndrome, a combination of disorders including insulin resistance, diabetes, dyslipidemia, and hypertension. A role for local glucocorticoid reamplification in obesity and the metabolic syndrome has been suggested. The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) regenerates active cortisol from inactive 11-keto forms, and aP2-HSD1 mice with relative transgenic overexpression of this enzyme in fat cells develop visceral obesity with insulin resistance and dyslipidemia. Here we report that aP2-HSD1 mice also have high arterial blood pressure (BP). The mice have increased sensitivity to dietary salt and increased plasma levels of angiotensinogen, angiotensin II, and aldosterone. This hypertension is abolished by selective angiotensin II receptor AT-1 antagonist at a low dose that does not affect BP in non-Tg littermates. These findings suggest that activation of the circulating renin-angiotensin system (RAS) develops in aP2-HSD1 mice. The long-term hypertension is further reflected by an appreciable hypertrophy and hyperplasia of the distal tubule epithelium of the nephron, resembling salt-sensitive or angiotensin II-mediated hypertension. Taken together, our findings suggest that overexpression of 1 11β-HSD1 in fat is sufficient to cause salt-sensitive hypertension mediated by an activated RAS. The potential role of adipose 11β-HSD1 in mediating critical features of the metabolic syndrome extends beyond obesity and metabolic complications to include the most central cardiovascular feature of this disorder.

UR - http://www.scopus.com/inward/record.url?scp=0041302382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041302382&partnerID=8YFLogxK

U2 - 10.1172/JCI200317845

DO - 10.1172/JCI200317845

M3 - Article

C2 - 12840062

VL - 112

SP - 83

EP - 90

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -